BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21836667)

  • 1. Molecular biology research in neuropsychiatry: India's contribution.
    Sathyanarayana Rao TS; Ramesh BN; Vasudevaraju P; Rao KS
    Indian J Psychiatry; 2010 Jan; 52(Suppl 1):S120-7. PubMed ID: 21836667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics approach to understanding interacting pathways in neuropsychiatric disorders.
    Alawieh A; Sabra Z; Nokkari A; El-Assaad A; Mondello S; Zaraket F; Fadlallah B; Kobeissy FH
    Methods Mol Biol; 2014; 1168():157-72. PubMed ID: 24870135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuropsychiatry of Parkinson's disease and related disorders.
    Lauterbach EC
    Psychiatr Clin North Am; 2004 Dec; 27(4):801-25. PubMed ID: 15550293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders.
    Murphy DL; Uhl GR; Holmes A; Ren-Patterson R; Hall FS; Sora I; Detera-Wadleigh S; Lesch KP
    Genes Brain Behav; 2003 Dec; 2(6):350-64. PubMed ID: 14653307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database.
    Li J; Cai T; Jiang Y; Chen H; He X; Chen C; Li X; Shao Q; Ran X; Li Z; Xia K; Liu C; Sun ZS; Wu J
    Mol Psychiatry; 2016 Feb; 21(2):290-7. PubMed ID: 25849321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual Research Review: The promise of stem cell research for neuropsychiatric disorders.
    Vaccarino FM; Urban AE; Stevens HE; Szekely A; Abyzov A; Grigorenko EL; Gerstein M; Weissman S
    J Child Psychol Psychiatry; 2011 Apr; 52(4):504-16. PubMed ID: 21204834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An updated overview of animal models in neuropsychiatry.
    Razafsha M; Behforuzi H; Harati H; Wafai RA; Khaku A; Mondello S; Gold MS; Kobeissy FH
    Neuroscience; 2013 Jun; 240():204-18. PubMed ID: 23473749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders.
    Patel S
    Adv Protein Chem Struct Biol; 2014; 94():39-75. PubMed ID: 24629185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of genetic and gene expression analysis in the diagnosis of neuropsychiatric disorders.
    van de Leemput J; Glatt SJ; Tsuang MT
    Expert Rev Mol Diagn; 2016 Jun; 16(6):677-95. PubMed ID: 27017833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems biology, bioinformatics, and biomarkers in neuropsychiatry.
    Alawieh A; Zaraket FA; Li JL; Mondello S; Nokkari A; Razafsha M; Fadlallah B; Boustany RM; Kobeissy FH
    Front Neurosci; 2012; 6():187. PubMed ID: 23269912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New technologies provide insights into genetic basis of psychiatric disorders and explain their co-morbidity.
    Rudan I
    Psychiatr Danub; 2010 Jun; 22(2):190-2. PubMed ID: 20562745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Big Data Analysis of Genes Associated With Neuropsychiatric Disorders in an Alzheimer's Disease Animal Model.
    Ham S; Kim TK; Hong H; Kim YS; Tang YP; Im HI
    Front Neurosci; 2018; 12():407. PubMed ID: 29962931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aligning physiology with psychology: Translational neuroscience in neuropsychiatric drug discovery.
    McArthur RA
    Neurosci Biobehav Rev; 2017 May; 76(Pt A):4-21. PubMed ID: 28434587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-9: A magic drug target in neuropsychiatry?
    Kaczmarek KT; Protokowicz K; Kaczmarek L
    J Neurochem; 2023 Oct; ():. PubMed ID: 37791997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of oxidative stress in the pathophysiology of neuropsychiatric disorders].
    Nunomura A; Tamaoki T; Motohashi N
    Seishin Shinkeigaku Zasshi; 2014; 116(10):842-58. PubMed ID: 25672211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 and the septohippocampal system: intrinsic actions and autoimmune processes relevant to neuropsychiatric disorders.
    Petitto JM; Huang Z; Meola D; Ha GK; Dauer D
    Methods Mol Biol; 2012; 829():433-43. PubMed ID: 22231830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative approach to neuropsychiatry: The why and the how.
    Kas MJ; Penninx B; Sommer B; Serretti A; Arango C; Marston H
    Neurosci Biobehav Rev; 2019 Feb; 97():3-9. PubMed ID: 29246661
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.